TNFRSF1A and nonpapillary renal cell carcinoma: TNFRSF1A was upregulated in ccRCC patients with tyrosine kinase inhibitor resistance and was an independent predictive factor for unfavorable response to tyrosine kinase inhibitor and shorter survivals [26].